PROGRAM
Date / Time : July 23-25, 2025
Venue : July 23 / 7F, TaiNEX2; July 24-25 / 4F, TaiNEX1
D&T | WED ‧ July 23 | THU ‧ July 24 | FRI ‧ July 25 | ||||
---|---|---|---|---|---|---|---|
09:00-12:00 |
Plenary |
Regional Collaboration Forum
|
Canada
|
||||
13:30-16:30 |
Australia Session
|
U.S.A Session |
Japan Session
|
India Session |
Belgium Session
|
Jul.23 - U.S.A
Taiwan-U.S. SMEs Biotech Forum & Business Opportunities Exchange
Room 702, TaiNEX2
Date / Time : July 23, 14:00 - 17:00
Venue: Room 701F, TaiNEX2
Organizers : Small and Medium Enterprise and Startup Administration, Ministry of Economic Affairs; American Institute in Taiwan (AIT)
Implementer: National Association of Small and Medium Enterprises
Co-Organizers: American State Offices Association (ASOA); Taiwan Bio Industry Organization
Duration | Topic | Speaker |
---|---|---|
13:30-14:00 | Registration |
|
14:00-14:03 | Welcome |
Felix Yen |
14:03-14:08 | Opening Remarks | GJ Lee Director General, Small and Medium Enterprise and Startup Administration, Ministry of Economic Affairs |
14:08-14:13 | VIP Remarks | Eric Crowley Acting Commercial Section Chief, AIT |
14:13-14:18 | MOU Signing Ceremony | |
14:18-14:20 | Group Photo | |
14:20-14:35 | Greater Philadelphia’s Premier Life Sciences Hub – Your Next Location for Innovation, R&D & Clinical Development | Bryan Tsao Manager, Life Science and Healthcare Initiatives, Chamber of Commerce for Greater Philadelphia |
14:35-14:50 | Taiwan Pharma’s Path to U.S. Market Success Through Strategic Investment (tentative) | JD Mowery Division President of the CDMO business, Bora Pharmaceuticals |
14:50-15:05 | Unlocking Potential for U.S. Pharma Manufacturing Experience and Opportunities for U.S.-Taiwan Cross-Border Collaboration | Chih-Wei Chien President, YungShin Global Holding Corporation |
15:05-15:50 | Panel Discussion- Taiwan-US Biotech and Medical Industry Cooperation Forum | Moderator: Wallace Lin Secretary General, Taiwan Bio Industry Organization Panelists: Seaton Smith CEO, LEO Verification Systems Inc. Click Wang Taiwan Business Leader, Illumina Taiwan Grace Shao Principal (Executive Partner), Baker McKenzie Pei-Chuan Huang Pharmaceutical, Biotechnology and CDMO Sector Leader, PricewaterhouseCoopers (PwC) |
15:50-16:00 | Break | |
16:00-17:00 | Partnering & Consulting | |
17:00 | Closing |
Date / Time : July 23 (Wed.) 13:00-17:30
Venue : Taipei Nangang Exhibition Center, Hall 2 (Room 703)
Co-organizer: The Australian Office Taipei, MTPConnect, Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO), Taiwan BIO Industry Association
Duration | Topic | Speaker |
---|---|---|
13:00 - 13:30 | Registration |
|
13:30 - 13:35 | Welcome Remarks |
Christopher Lim |
13:35 - 13:45 | Taiwan Biotech Industry Overview | Dr Michael Huang Director, Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) & Vice President, Innovation and Entrepreneur Core, DCB |
13:45 - 13:55 | Keynote: Australia – A go-to destination for clinical trials |
Stuart Dignam Chief Executive Officer, MTPConnect |
13:55 - 14:03 | Insights from CRO specialists on Australia’s Pre-Clinical capabilities | Stefan Cross Chief Executive Officer, Crux Biolabs |
14:03 - 14:11 | World-class Clinical Trial Facilities – Phase 1 Unit | Salmaan Naqvi Chief Commercial Officer, Veritus Research |
14:11 - 14:19 | End-to-End Clinical Trial Support - Full-service CRO solutions | Jovana Milosevic Head of CRO, Genesis Care CRO |
14:19 - 14:27 | Services from Contract Development and Manufacturing Organizations (CDMO) | Chih Wei Teng Vice President Corporate Development, CCRM Australia |
14:27 - 14:35 | Clinical Trial Supply Chain | Karen Montgomery-Douglas Commercial Development Manager, Akesa |
14:35 - 14:43 | Attractive Research & Development Tax Incentives | Pavel Reddy Founder/ Director, Global R&D |
14:43 - 14:51 | Case Study - Success Story from Belite | Jane Chiu VP of Clinical Operations |
14:51 - 15:51 | One-on-one Meetings | |
16:00 - 17:30 | Networking Reception |
Session Introduction
Australia has a worldwide reputation for its clinical trials destination because of its quality, speed and cost of our clinical trials governance. You will hear from leading clinical trials-related service providers from Australia to share their experience and insights in conducting trials in Australia.
In this forum, you will meet 24 leading and experienced clinical trial service providers from Australia, including CROs, trial sites, bio labs, CDMOs, depots, and company specialising in knowledge-based software development for drug discovery, corporate services, and R&D tax incentives.
Date / Time : July 24 (Thur.) 9:00-12:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 404)
Co-organizer: Taiwan Bio Industry Organization, Taiwan External Trade Development Council, Biotechnology and Pharmaceutical Industries Promotion Office, MOEA, Taiwan Stock Exchange
Duration | Topic | Speaker |
---|---|---|
09:00-9:30 | Registration |
|
09:30-09:40 | Opening Remarks |
Simon Wang
|
09:40-09:55 | BIO Asia Awards-Successful Stories (1) Topic TBD |
Yasuko TERAO |
09:55-10:10 | BIO Asia Awards-Successful Stories (2) |
TBD |
10:10-10:25 | BIO Asia Awards-Successful Stories (3) |
TBD |
10:25-10:40 | Cultivate Business Growth by Listing on Taiwan Stock Exchange |
Blake Tsai |
10:40-10:55 | Singapore: Bridging East-West Biotech Opportunities |
Goh Wan Yee |
10:55-11:05 | Break |
|
11:05-11:55 | Regional Collaboration Summit-Partnership, Collaboration & Synergy |
Claire Skentelbery
Chair, The International Council of Biotechnology Associations (ICBA) Kelly Seagraves
Vice President for National Security and International Affairs, Biotechnology Innovation Organization (BIO) Yoshiaki Tsukamoto
Executive Vice President, Japan Bioindustry Association Murali Panchapagesa Muthuswamy
Chairman, Jananom Private Limited Representative from Australia, Canada, Belgium, Korea
|
11:55-12:00 | Closing |
Session Introduction
Date / Time : July 24 15:00-16:35
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 404)
Co-organizer: Japan Bioindustry Association Biotechnology and Pharmaceutical Industries Promotion Office, Ministry of Economic Affairs, Taiwan
Duration | Topic | Speaker |
---|---|---|
15:00-15:05 | Opening Remarks 1 |
Prof. Yoshiaki Tsukamoto |
15:05-15:10 | Opening Remarks 2 |
Dr. Michael Huang |
15:10-15:15 | Japan’s Bioeconomy Strategy and Greater Tokyo Biocommunity |
Prof. Yoshiaki Tsukamoto |
15:15-15:30 | Research Strategy and Open Innovation at Daiichi Sankyo | |
15:30-15:45 | Advancing Regenerative Medicine from Japan to Asia: Product Development, CDMO Services, and Bioprocess Solutions | |
15:45-16:00 | GEXVal Inc: Japan’s Emerging Biopharma to Reach the Unreached | |
16:00-16:15 | Collaboration with Asian Partners |
Tadashi Matsumoto, Ph.D., MBA. |
16:15-16:35 | Panel Discussion |
Moderator:
Panelists:
|
Session Introduction
Japan has one of the most active biotechnology industries in the world, as evidenced by the large number of patent applications and products in the real market. Every day, many pharmaceutical, biotech, medical and healthcare companies, from startups to large corporations, are applying various types of biotechnologies to their businesses and developing novel products.
As seen in the examples of pharmaceutical development in recent years, it has increasingly become difficult for a single company to develop a product by itself, leading to the increasing demands for the opportunities for external collaboration in the areas of R&D and manufacturing. Those current streams enhance the importance of bioecosystems, which include open innovation and outsourced research activities and manufacturing for companies. The government of Japan has released the Bioeconomy Strategy in 2019, concentrating on the formation of bioecosystem, and Japanese academia, local governments and bioindustries are now extensively working according to this strategy.
In light of this circumstances, we have planned this session to introduce current situation of bioecosystems in Japan and leading four excellent Japanese companies, all of which are aggressive in collaborating with Taiwan bioindustry players. We are sure that you will have a chance to hear about their strategies and plans for the collaboration.
We hope that this session will help you accelerate collaborations with Japanese companies.
Jul.25 - Canada
Canada-Taiwan Health & Medtech Partnering Forum AI, Precision Health, Eldercare
Room 501,502 TaiNEX1
Date / Time : July 25 (Fri.)9:00-16:30
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 501,502)
Co-organizer: Canadian Trade Office in Taipei, Alberta Taiwan Office, British Columbia Taiwan Office, Biotech and Pharmaceutical Industries Promotion Office, MOEA, Industrial Technology Research Institute, National Research Council Canada
Duration | Topic | Speaker |
---|---|---|
08:30 – 09:00 | Registration |
|
09:00 – 09:15 | Opening Remarks |
Ed Jager |
09:15 – 09:45 | Keynote Building Inclusive Smart Health Futures: A Taiwan–Canada Perspective |
Dr. Jessy Kang CEO, Jubo Health Technologies |
09:45 – 10:25 | Canada-Taiwan Collaboration in Action NRC Multi-functional gloves for dexterity rehabilitation ITRI Enabling Service System Technology |
Mark Hewko Team Lead, Medical Devices Research Centre, NRC Dr. Hung-Dun Lin Division Director, Service Systems Technology Center |
10:25 – 10:40 | Health Break & Product Showcase | |
10:40 – 11:20 | Modelling for the Future & Community Health System Seeing – Augmenting Individual Health Perspectives with a 6D Digital AI Lens Visualizing Interconnected Place, Time, Context, and People-based Relationships |
Myrna Bittner CEO Founder, Runwithit Synthetics |
11:20 – 11:50 | Inference AI in Pharmaceuticals ProHolistic Discovery: Elevating Clinical Success with Holistic Drug Discovery |
Dr. Richard Tseng President, Proholistic Discovery |
11:50 – 12:00 | Q & A | |
12:00 – 13:00 | Lunch Break | |
13:00 – 13:10 | Introduction to the Canadian International Innovation Program (CIIP)* | |
13:10 – 13:40 | Nature Inspired MedTech Innovation The Power of Biofeedback to Restore Calm |
Ben Brzezynski MindfulGarden Digital Health |
13:40 – 14:10 | Redefining Care with Precision Diagnostics Precision Diagnostics for Improved Care and Outcomes |
Dr. Pinaki Bose Executive Vice-President, OncoHelix |
14:10 – 14:40 | Innovation in Heart Failure Management Development of Rapid Point of Care Diagnostics for Cardiac Biomarkers – Role of artificial intelligence |
Dr. Vivek Venu Project Lead, CardiAI |
14:40 – 14:45 | Q & A | |
14:45 – 15:00 | Health Break & Product Demo | |
15:00 – 17:15 | One on one meetings & Networking |
Session Introduction
Canada boasts a well-established life sciences sector and developed key strengths in AI, precision health, digital health and medtech thanks to its thriving innovation ecosystem and open business environment, underpinned by a national AI strategy.
With more than 1,000 companies and CA$87.4 billion in revenues, Canadian life science companies are distributed across Canada, with robust clusters in Alberta and British Columbia. In partnership with these two provincial governments, the National Research Council Canada (NRC) and Taiwan’s Industrial Technology Research Institute (ITRI), the Canadian Trade Office in Taipei (CTOT) is excited to host a Canada-Taiwan Health and Medtech Partnering Forum on Friday, July 25, 2025, during BIO Asia–Taiwan 2025, featuring five outstanding Canadian firms presenting their latest AI, precision health, pharmaceutical, and medical device solutions. Taiwanese senior care company, Jubo Health, will share its experience and insights on Canada-Taiwan business and tech collaboration, and a cutting-edge rehabilitation glove jointly developed by NRC and ITRI will also be showcased at the event.
Don’t miss this opportunity to hear from the Canadian businesses and meet with them one-on-one to discuss potential partnership opportunities. Participants will also learn about how to leverage the Canadian International Innovation Program (CIIP)*!
Successfully registered participants will receive a confirmation email five days prior to the event.* Known as ‘A+ Industrial Innovative R&D Program’ in Taiwan (A+企業創新研發淬鍊計劃).
Jul.25 - Belgium
2025 Taiwan–Belgium Smart Healthcare Forum & Matchmaking Event
Register
Room 500, Hall 1
Date / Time : July 25 (Fri.)13:30-17:30
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 500)
Co-organizers : Small and Medium Enterprise and Startup Administration (SMESA), Ministry of Economic Affairs (MOEA), Wallonia Export & Investment Agency (AWEX), Institute for Information Industry (III), National Biotechnology Research Park (NBRP), Development Center for Biotechnology (DCB), Nangang Biotechnology Incubation Center (NBIC), National Health Research Institutes (NHRI), Taiwan Bio Industry Organization, TMU BioMed Accelerator, BE Health Accelerator, TAITRA (Taiwan External Trade Development Council), Enterprise Europe Network (EEN)
Duration | Topic | Speaker |
---|---|---|
13:30–14:00 | First Session :Taiwan–Belgium Smart Healthcare Forum Registration |
|
14:00–14:02 | Officially Start |
|
14:02–14:12 | Opening Remarks | Representatives from SMESA Philippe Lachapelle Director of Technical Partnerships and Networks of Innovation, AWEX |
14:12–14:15 | Group Photo | |
14:15–14:30 | Taiwan–Belgium Smart Healthcare Landscape Keynote Speech 1: Taiwan Smart Healthcare Trends |
Representative from National Biotechnology Research Park (NBRP) |
14:30–14:45 | Keynote Speech 2: Belgium Smart Healthcare Trends |
Fabrizio Giannotta Business Coach, Ignity SA |
14:45–15:00 | Business Cases in Cross-Border Collaboration Keynote Speech 3: Synergy & Expectations between Taiwan & Belgium Medtech Partnership |
Jimmy Chang Entrepreneur in Residence, BE Accelerator |
15:00–15:15 | Keynote Speech 4: Smart Healthcare Cross-Border Collaboration: Belgium’s Experience |
Representative from Belgium Smart Healthcare Company |
15:15–15:25 | Second Session : Matchmaking Event Coffee Break & Registration for Afternoon Session |
|
15:25–15:30 | Matchmaking Description | *Moderator |
15:30–17:30 | One-on-One B2B Matchmaking | *Approx. 15–20 minutes per session |
17:30 | Networking |
Jul.25 - India
Regional Collaboration Forum-India Session
Room 402C, Hall 1
Date / Time : July 25 (Fri.) 13:30-15:40
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402C)
Co-organizer: India Taipei Association
Duration | Topic | Speaker |
---|---|---|
13:30-14:00 | Registration |
|
14:00-14:10 | Opening Remarks and Potential of Biomedical Industry in India |
Mr. Manharsinh L. Yadav |
14:10-14:30 | Introduction of India Biotech Ecosystem | Dr. Murali Panchapagesa Muthuswamy Chairman, Jananom Private Limited (Inviting) |
14:30-14:50 | Globalization of Indian Pharma and Dr.Reddy’s experience sharing | Dr. Satheeshkumar Sriharan Group Country Head for China Mainland and Taiwan, Dr. Reddy's Laboratories |
14:50-15:10 | Presentation by Hectero | Dr. Puneeth Kumar Surupa Country Manager of Taiwan & HongKong, Hetero |
15:10-15:30 | Successful Story Sharing: Taiwan-India Cooperation | Yon-Lian Wu Founder, Chairman & CEO, Sunny Pharmtech |
15:30-15:40 | Conclusion |